WeedPress: The Paper Trail

2018 World Health Organization Convenes Special Session On CBD

—

by

Jason Karimi, WeedPress Contributor
in ,

Heard through MedPharm Iowa’s Rebecca Lucas comes this update in 2018 from the World Health Organization. Check out the science below:

World Health Organization
WHO science review 2018: SAFE

https://www.who.int/medicines/access/controlled-substances/ecdd_40_meeting/en/?fbclid=IwAR3crsPpAQ_ODPqcFr-_nFOnx2hIriOJ9Fkhtu3Wuw1nfvFyDt2RmvtShZQ

Essential medicines and health products

Fortieth meeting of the Expert Committee on Drug Dependence

The Fortieth meeting of the Expert Committee on Drug Dependence (ECDD) was held in Geneva, Switzerland, 4-7 June 2018.

The 40th ECDD was a specially convened session dedicated to carrying out pre-reviews of cannabis and cannabis-related substances:

  • Cannabis plant and cannabis resin
  • Extracts and tinctures of cannabis*
  • Delta-9-tetrahydrocannabinol (THC)
  • Isomers of THC

In addition to these pre-reviews, the Committee undertook a critical review of Cannabidiol (CBD).

For more information, please do not hesitate to contact the Secretariat at: ecddsecretariat@who.int

Meeting documents

Open session

Meeting outcomes

The 40th ECDD technical documents

Critical review: Cannabidiol

Pre-review: Cannabis plant and resin

Pre-review: Extracts and tinctures of cannabis

Pre-review: delta-9-tetrahydrocannabinol (THC)

Pre-review: Isomers of THC

Questionnaires

AddThis Sharing Buttons

Share to Print

Share to Google+Share to More

Comments

Leave a comment

Is this your new site? Log in to activate admin features and dismiss this message
Log In